Concepedia
Statistics
Publications
60
Citations
3.8K
H-Index
34
Active since
1993
Affiliations
Inserm(Current)
Université de Rennes
Institut de Recherche en Santé, Environnement et Travail
Structure Fédérative de Recherche en Biologie et Santé de Rennes
Vanderbilt University
Sophie Langouët is an author at Inserm specializing in medicine, pharmacology, and liver physiology.
Top concepts
MedicineLiver PhysiologyPharmacologyBiochemistryCell BiologyOxidative StressHepatologyToxicologyMetabolismMetabolomics
Publications per year
1993–2023
EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS
Caroline Aninat, Amélie Piton, Denise Glaise et al. · Drug Metabolism and Disposition · 2005 · 669 citations
Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.
Laurence Berthou, Nicolas Duverger, F. Emmanuel et al. · Journal of Clinical Investigation · 1996 · 250 citations · Full text
Molecular Regulation, Genetics, Lipid Peroxidation +26
Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes.
Karine Mahéo, Franck Morel, Sophie Langouët et al. · PubMed · 1997 · 231 citations
Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture.
Sophie Langouët, B Coles, Franck Morel et al. · PubMed · 1995 · 154 citations
Lipid Peroxidation, Redox Biology, Toxicological Mechanism +21
Inhibition of Human Cytochrome P450 Enzymes by 1,2-Dithiole-3-thione, Oltipraz and Its Derivatives, and Sulforaphane
Sophie Langouët, Laura Lowe Furge, Nathalie Kerriguy et al. · Chemical Research in Toxicology · 2000 · 116 citations
1–5 of 60